(Q36494133)

14 August 2017

Low-dose aspirin and breast cancer risk: results by tumour characteristics from a randomised trial (English)

1 reference

14 August 2017

1 reference

5

J E Buring

1 reference

14 August 2017

3

J E Manson

1 reference

14 August 2017

2

N R Cook

1 reference

14 August 2017

S M Zhang

1

1 reference

14 August 2017

I-M Lee

series ordinal

4

1 reference

14 August 2017

language of work or name

English

0 references

publication date

12 February 2008

1 reference

British Journal of Cancer

14 August 2017

1 reference

14 August 2017

98

1 reference

14 August 2017

5

1 reference

14 August 2017

989-991

1 reference

Nonsteroidal antiinflammatory drugs and breast cancer risk: the multiethnic cohort

14 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2266841

Association between frequent use of nonsteroidal anti-inflammatory drugs and breast cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2266841

Low-dose aspirin in the primary prevention of cancer: the Women's Health Study: a randomized controlled trial

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2266841

Nonsteroidal anti-inflammatory drug use and breast cancer risk by stage and hormone receptor status

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2266841

Risk of breast cancer among users of aspirin and other anti-inflammatory drugs

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2266841

Aspirin and breast cancer prevention: the estrogen connection

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2266841

Association of frequency and duration of aspirin use and hormone receptor status with breast cancer risk

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2266841

Breast cancer and nonsteroidal anti-inflammatory drugs: prospective results from the Women's Health Initiative

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2266841

Suppression of human colorectal mucosal prostaglandins: determining the lowest effective aspirin dose

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2266841

Overexpression of cyclooxygenase-2 is sufficient to induce tumorigenesis in transgenic mice

30 September 2017

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18268496

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Prognostic significance of elevated cyclooxygenase-2 expression in breast cancer

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18268496

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

NSAID use and breast cancer risk in the VITAL cohort

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FSJ.BJC.6604240

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.BJC.6604240

1 reference

14 August 2017

1 reference

14 August 2017

PubMed publication ID

18268496

1 reference